Brave Little World: Spheroids as an in vitro Model to Study Tumor-Immune-Cell Interactions
暂无分享,去创建一个
Leoni A. Kunz-Schughart | R. Andreesen | L. Kunz-Schughart | M. Kreutz | Marina Kreutz | Reinhard Andreesen | Eva Gottfried | E. Gottfried
[1] K. Papas,et al. Change in lactate production in Myc‐transformed cells precedes apoptosis and can be inhibited by Bcl‐2 overexpression , 1999, FEBS letters.
[2] R. Audran,et al. Interactions between human macrophages and tumor cells in three-dimensional cultures , 1994, Cancer Immunology, Immunotherapy.
[3] J. M. Arbeit,et al. Coordinate up-regulation of hypoxia inducible factor (HIF)-1alpha and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing. , 2000, Cancer research.
[4] A. Harris,et al. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. , 1996, Cancer research.
[5] H. Lyng,et al. Correlation of high lactate levels in head and neck tumors with incidence of metastasis. , 1997, The American journal of pathology.
[6] J. Abbruzzese,et al. Regulation of vascular endothelial growth factor expression by acidosis in human cancer cells , 2001, Oncogene.
[7] J. Blay,et al. IL-4 prevents the blockade of dendritic cell differentiation induced by tumor cells. , 2001, Cancer research.
[8] P. Allavena,et al. Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression. , 2004, European journal of cancer.
[9] B. Ebert,et al. Isoenzyme-specific regulation of genes involved in energy metabolism by hypoxia: similarities with the regulation of erythropoietin. , 1996, The Biochemical journal.
[10] A. Mui,et al. SHIP represses the generation of alternatively activated macrophages. , 2005, Immunity.
[11] S. Koyasu,et al. IFN‐γ and pro‐inflammatory cytokine production by antigen‐presenting cells is dictated by intracellular thiol redox status regulated by oxygen tension , 2002, European journal of immunology.
[12] H. Bitterman,et al. Hypoxia reduces CD80 expression on monocytes but enhances their LPS-stimulated TNF-alpha secretion. , 2003, Journal of leukocyte biology.
[13] J. Morton,et al. CD1a-positive infiltrating-dendritic cell density and 5-year survival from human breast cancer , 2003, British Journal of Cancer.
[14] A. Lardner. The effects of extracellular pH on immune function , 2001, Journal of leukocyte biology.
[15] R. Andreesen,et al. Three‐dimensional co‐culture of human monocytes and macrophages with tumor cells: Analysis of macrophage differentiation and activation , 1996, International journal of cancer.
[16] F. Mullick,et al. Presence and Localization of Three Lactic Acid Transporters (MCT1, −2, and −4) in Separated Human Granulocytes, Lymphocytes, and Monocytes , 2004, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[17] R. Sutherland. Cell and environment interactions in tumor microregions: the multicell spheroid model. , 1988, Science.
[18] W. Kaelin,et al. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[19] A. Enk,et al. Induction of tolerance by IL-10-treated dendritic cells. , 1997, Journal of immunology.
[20] A. Puig-Kröger,et al. Peritoneal dialysis solutions inhibit the differentiation and maturation of human monocyte‐derived dendritic cells: effect of lactate and glucose‐degradation products , 2003, Journal of leukocyte biology.
[21] D. Carbone,et al. Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells. , 1998, Journal of immunology.
[22] F. Balkwill,et al. Inhibition of monocyte and macrophage chemotaxis by hypoxia and inflammation – a potential mechanism , 2001, European journal of immunology.
[23] A. Enk,et al. Dendritic cells as mediators of tumor‐induced tolerance in metastatic melanoma , 1997, International journal of cancer.
[24] R. Knuechel,et al. Tumor‐associated fibroblasts recruit blood monocytes into tumor tissue , 2003, European journal of immunology.
[25] W. Frankel,et al. Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles , 2004, Oncogene.
[26] S. Tsujitani,et al. Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue. , 1998, British Journal of Cancer.
[27] M. Mori,et al. S‐100 protein‐positive dendritic cells in colorectal adenocarcinomas. Distribution and relation to the clinical prognosis , 1989, Cancer.
[28] Dirk Schadendorf,et al. Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells , 1998, Nature Medicine.
[29] S. Dubinett,et al. Tumors Promote Altered Maturation and Early Apoptosis of Monocyte-Derived Dendritic Cells1 , 2000, The Journal of Immunology.
[30] Y. Maehara,et al. Lymph node metastasis and relation to tumor growth potential and local immune response in advanced gastric cancer. , 1997, International journal of cancer.
[31] R K Jain,et al. Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo. , 2001, Cancer research.
[32] A. Paetau,et al. Effect of LAK cells against three-dimensional tumor tissue. In vitro study using multi-cellular human glioma spheroids as targets. , 1989, Journal of immunology.
[33] L. Kunz-Schughart,et al. The fibroblast: Sentinel cell and local immune modulator in tumor tissue , 2004, International journal of cancer.
[34] M. Merad,et al. Induction of potent antitumor immunity by in situ targeting of intratumoral DCs. , 2004, The Journal of clinical investigation.
[35] R. Jove,et al. Hyperactivation of STAT3 Is Involved in Abnormal Differentiation of Dendritic Cells in Cancer , 2004, The Journal of Immunology.
[36] R. Andreesen,et al. Identification of genes expressed in tumor-associated macrophages. , 2003, Immunobiology.
[37] K. O'Byrne,et al. Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] D. Hart,et al. Review: Dendritic Cells and Cancer: Progress Toward a New Cellular Therapy , 1997 .
[39] T. Schroeder,et al. Lactate in solid malignant tumors: potential basis of a metabolic classification in clinical oncology. , 2004, Current medicinal chemistry.
[40] H. Klocker,et al. Human renal‐cell carcinoma tissue contains dendritic cells , 1996, International journal of cancer.
[41] A. Sica,et al. A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). , 2006, Blood.
[42] M. Goldman,et al. Interleukin‐10 differentially regulates B7‐1 (CD80) and B7‐2 (CD86) expression on human peripheral blood dendritic cells , 1995, European journal of immunology.
[43] D. Carbone,et al. Clinical significance of defective dendritic cell differentiation in cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[44] A. Mackensen,et al. Tumor-derived lactic acid modulates dendritic cell activation and antigen expression. , 2006, Blood.
[45] D. Carbone,et al. Defective function of Langerhans cells in tumor-bearing animals is the result of defective maturation from hemopoietic progenitors. , 1998, Journal of immunology.
[46] L. Kunz-Schughart,et al. Multicellular tumor spheroids: intermediates between monolayer culture and in vivo tumor , 1999, Cell biology international.
[47] C. Lewis,et al. Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy. , 2003, The American journal of pathology.
[48] A. Harris,et al. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. , 2000, The American journal of pathology.
[49] J. Banchereau,et al. In Breast Carcinoma Tissue, Immature Dendritic Cells Reside within the Tumor, Whereas Mature Dendritic Cells Are Located in Peritumoral Areas , 1999, The Journal of experimental medicine.
[50] P. Hahnfeldt,et al. Mammary fibroblasts may influence breast tumor angiogenesis via hypoxia-induced vascular endothelial growth factor up-regulation and protein expression. , 1994, Cancer research.
[51] O. Warburg. [On the facultative anaerobiosis of cancer cells and its use in chemotherapy]. , 1961, Munchener medizinische Wochenschrift.
[52] R. Foà,et al. The circulating dendritic cell compartment in patients with chronic lymphocytic leukemia is severely defective and unable to stimulate an effective T-cell response. , 2003, Cancer research.
[53] Hua Yu,et al. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells , 2004, Nature Medicine.
[54] Stefan Walenta,et al. Lactate: mirror and motor of tumor malignancy. , 2004, Seminars in radiation oncology.
[55] Huasheng Lu,et al. Hypoxia-inducible Factor 1 Activation by Aerobic Glycolysis Implicates the Warburg Effect in Carcinogenesis* , 2002, The Journal of Biological Chemistry.
[56] R. Andreesen,et al. Cytokine repertoire during maturation of monocytes to macrophages within spheroids of malignant and non‐malignant urothelial cell lines , 1998, International journal of cancer.
[57] D. Carbone,et al. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells , 1996, Nature Medicine.
[58] Ugur Sahin,et al. Human Cancer , 2006 .
[59] S. Hauptmann,et al. Macrophages and multicellular tumor spheroids in co-culture: a three-dimensional model to study tumor-host interactions. Evidence for macrophage-mediated tumor cell proliferation and migration. , 1993, American Journal of Pathology.
[60] T. Ogata,et al. Immunohistochemical analysis of dendritic/Langerhans cells in thyroid carcinomas. , 1995, Analytical Cellular Pathology.
[61] D. Gabrilovich,et al. STAT1 Signaling Regulates Tumor-Associated Macrophage-Mediated T Cell Deletion1 , 2005, The Journal of Immunology.
[62] Yi-Chen Lin,et al. Tumor-associated macrophages: the double-edged sword in cancer progression. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[63] R. Knuechel,et al. Multicellular spheroids: a three‐dimensional in vitro culture system to study tumour biology , 1998, International journal of experimental pathology.
[64] J. Faivre,et al. Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[65] C. Scotton,et al. Hypoxia inhibits macrophage migration , 1999, European journal of immunology.
[66] D. Carbone,et al. Differential Roles of Vascular Endothelial Growth Factor Receptors 1 and 2 in Dendritic Cell Differentiation1 , 2005, The Journal of Immunology.
[67] J. Blay,et al. Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor. , 1998, Blood.
[68] James P. Freyer,et al. The Use of 3-D Cultures for High-Throughput Screening: The Multicellular Spheroid Model , 2004, Journal of biomolecular screening.
[69] N. Price,et al. The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. , 1999, The Biochemical journal.
[70] Naiem A. Zeid,et al. S 100 Positive Dendritic Cells In Human Lung Tumors Associated With Cell Differentiation And Enhanced Survival , 1993, Pathology.
[71] F. Balkwill,et al. Hypoxia down‐regulates MCP‐1 expression: implications for macrophage distribution in tumors , 1998, Journal of leukocyte biology.
[72] E. Rofstad,et al. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. , 2000, Cancer research.